The number of articles covering the amazing combination of AKIDA technology with NaNose sensors for detecting Covid-19 is starting to gain Global news traction. The following article is the English translation of an article that has appeared in Germany. If you want to go looking there are many more and by Monday should have a lot of people talking not just Hot Copper. This will in my opinion put Brainchip on the front page for all the right reasons:
AI chip detects Covid-19 in the breath
February 26, 2021,8:33 am | Heinz Arnold
With the help ofBrain-Chip's neuromorphic AI processor, the NaNose portable diagnostic testdevice detects Covid-19.
Test for Corona very easily, butprecisely, quickly and inexpensively:
Nothing stands in the way of this now:The artificial nose from NaNose Medical in combination with the "Akida" processor from Brain-Chip , which is based on a Spiking Neural Network, can do Corona in one recognize very early stage. The diagnostic device fits in one hand and is similar to the well-known alcohol test devices. Now nothing stands in the way of the widespread dissemination of tests, so that corona outbreaks can be localized and mortality reduced.
According to NaNose Medical, theartificial nose developed at the Technion, the Israeli Institute of Technology,has the same high sensitivity to tiny amounts of volatile organic compounds(VOCs) in the breath as a dog's nose. Since 2017, it has been tested onthe Technion to detect diseases such as cancer, Parkinson's, multiplesclerosis, kidney disease, and infections such as Covid-19.
NaNose Medical collected samples from130 patients and transferred the sensor data to the Brainchip researchinstitute in Perth / Australia. With this data, Brainchip trained theAkida. Samples from patients suffering from Covid-19 and samples from non-infectedpatients were presented to the system. On the basis of this data, thesystem learned the typical patterns of the VOC biomarkers that mark aninfection to identify within seconds - and with high accuracy. NaNose iscurrently collecting samples from three critical locations around the world andis cooperating with Brainchip to evaluate the data.
The key to corona containment
A study from China shows that themethod of detecting Covid-19 by analyzing the breath is more precise than thereverse transcription polymerase chain reaction (RT-PCR), which is mostly usedin corona tests today comes. However, an accurate test at an early stageof the disease is the key to containing the spread of corona. Because ifCorona is detected before the infected perceive the typical symptoms, they canbe saved from infecting others.
Because "Akida" is a complete neuromorphic processor , it does not require an external CPU and can work in edge devices. An additional deep learning accelerator or additional storage is also not required. This means that the test device based on it is very small, requires little power consumption and fits in one hand, similar to the breathalyzer.
"AI is finding its way intomedical technology and healthcare and we want to be at the forefront with theneuromorphic AI processor" Akida "for use in edge devices," saysLouis DiNardo, CEO of BranChip.
The Akida is already used in varioussectors in the medical field: To detect diseases using biomarkers in the bloodand breath, to detect deviations in X-ray and CT images, and in cancerdiagnostics.
Basically, BrainChip is targetingvarious market sectors with the “Neuromorphic System-on-Chip” of the “Akida”type, with its IP and the “Akida Development Environment Machine LearningFramework”, from healthcare to smart homes, smart cities and smarttransportation.
https://www.elektroniknet.de/halbleiter/ki-chip-entdeckt-covid-19-im-atem.184046.html
(20min delay)